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ABSTRACT Human infection with Cryptococcus causes up to a quarter of a million
AIDS-related deaths annually and is the most common cause of nonviral meningitis
in the United States. As an opportunistic fungal pathogen, Cryptococcus neoformans
is distinguished by its ability to adapt to diverse host environments, including
plants, amoebae, and mammals. In the present study, comparative transcriptomics of
the fungus within human cerebrospinal ﬂuid identiﬁed expression proﬁles represen-
tative of low-nutrient adaptive responses. Transcriptomics of fungal isolates from a
cohort of HIV/AIDS patients identiﬁed high expression levels of an alternative carbon
nutrient transporter gene, STL1, to be associated with poor early fungicidal activity,
an important clinical prognostic marker. Mouse modeling and pathway analysis
demonstrated a role for STL1 in mammalian pathogenesis and revealed that STL1 ex-
pression is regulated by a novel multigene regulatory mechanism involving the
CAC2 subunit of the chromatin assembly complex 1, CAF-1. In this pathway, the
global regulator of virulence gene VAD1 was found to transcriptionally regulate a
cryptococcal homolog of a cytosolic protein, Ecm15, in turn required for nuclear
transport of the Cac2 protein. Derepression of STL1 by the CAC2-containing CAF-1
complex was mediated by Cac2 and modulated binding and suppression of the STL1
enhancer element. Derepression of STL1 resulted in enhanced survival and growth of
the fungus in the presence of low-nutrient, alternative carbon sources, facilitating
virulence in mice. This study underscores the utility of ex vivo expression proﬁling of
fungal clinical isolates and provides fundamental genetic understanding of sapro-
phyte adaption to the human host.
IMPORTANCE Cryptococcus is a fungal pathogen that kills an estimated quarter of a
million individuals yearly and is the most common cause of nonviral meningitis in
the United States. The fungus is carried in about 10% of the adult population and,
after reactivation, causes disease in a wide variety of immunosuppressed individuals,
including the HIV infected and patients receiving transplant conditioning, cancer
therapy, or corticosteroid therapy for autoimmune diseases. The fungus is widely
carried in the soil but can also cause infections in plants and mammals. However,
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the mechanisms for this widespread ability to infect a variety of hosts are poorly un-
derstood. The present study identiﬁed adaptation to low nutrients as a key property
that allows the fungus to inhabit these diverse environments. Further studies identi-
ﬁed a nutrient transporter gene, STL1, to be upregulated under low nutrients and to
be associated with early fungicidal activity, a marker of poor clinical outcome in a
cohort of HIV/AIDS patients. Understanding molecular mechanisms involved in adap-
tation to the human host may help to design better methods of control and treat-
ment of widely dispersed fungal pathogens such as Cryptococcus.
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Cryptococcus neoformans is a major fungal pathogen causing a highly lethal menin-goencephalitis (CM), primarily in individuals with impaired host cell immunity, such
as those infected with HIV/AIDS, causing a quarter of a million deaths annually (1, 2).
Mortality exceeds 20 to 50% despite therapy (3), and recent failed attempts to improve
outcomes (4) highlight our profound lack of understanding of the pathophysiology of
human infections. While studies in host models such as mice or invertebrates have
generated essential insights into fungal virulence, evolutionary differences in host
response and pathogen environment suggest a need to model studies using human
disease correlates (5).
Peculiar to Cryptococcus is the ability to live for extended periods both within the
environment (6) and within the mammalian host in a dormant state (7). It can also
cause disease in a wide variety of plants (8), free-living amoebae (9), and humans (10).
Similarities between mammalian host environments such as the macrophage phagoly-
sosome and those more primitive organisms such as amoebae have been implicated as
exerting evolutionary pressure on facultative intracellular pathogens, such as C. neo-
formans (11), and gene expression studies suggest adaptation to nutrient deprivation
is important within this environment (12). Indeed, requirements for the gluconeogen-
esis enzyme Pck1 (13) and a high-afﬁnity glucose transporter (14) suggest roles for
nutrient homeostasis in cryptococcal virulence. Phagocytosis also stimulates a starva-
tion response in other pathogenic fungi, such as Candida albicans, that induce a shift
to fatty acids as a carbon source by upregulating the glyoxylate cycle, requiring the
enzyme isocitrate lyase (15). However, the dispensability of isocitrate lyase by C.
neoformans during infection suggests that species-speciﬁc pathways for starvation
tolerance are also important within the mammalian host (16). In addition, induction of
the nutrient-recycling autophagy pathway is particularly important for C. neoformans
but less important for other fungal pathogens such as Aspergillus and Candida (17). For
this important stress response, global nutrient regulators such as the target of rapa-
mycin (TOR) (18) play an important link between cryptococcal starvation response,
macrophage survival, and pathogen ﬁtness (19). In addition, downstream of TOR the
virulence-associated dead box protein, Vad1, has been shown to act as a global
posttranscriptional regulator of TOR-dependent processes, such as autophagy (19).
Similarly, the role of the cAMP nutrient-sensing pathway has featured prominently in
cryptococcal pathogenesis (20). In this pathway, adenylyl cyclase is activated by a G
subunit (Gpa1), resulting in the production of cAMP that binds to regulatory subunit
Pkr1 of the protein kinase A (PKA) complex to release an active form of the catalytic
subunit Pka1, which activates downstream proteins (21). However, little is known
regarding regulatory relationships that link these nutrient master regulators and gene
targets responsible for mammalian virulence, as well as possible commonalities be-
tween the various infective environments, including humans.
Previous studies have not always found robust quantitative relationships between
mammalian infectious outcome and classical virulence factors in vitro (22, 23), implying
that other mechanisms of virulence remain to be identiﬁed. Thus, in the present work,
to characterize virulence-associated starvation responses most relevant to human
infections, transcriptional proﬁling of the fungus inoculated into human cerebrospinal
ﬂuid (CSF) was ﬁrst compared to that from a starvation medium previously used to
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identify a clinical association between expression levels of a CTR4 copper transporter
and dissemination to the brain in a cohort of human solid organ transplant patients
(24). Comparison of the expression proﬁles of fungus incubated in human cerebrospinal
ﬂuid or under nutrient deﬁciency identiﬁed a large set of 855 genes upregulated under
both conditions. To identify genes within this subgroup whose expression might be
most relevant to human infections, we compared transcription proﬁles of isolates from
those who died versus those surviving 10 weeks obtained from a previously described
cohort of HIV/AIDS-infected patients with CM (23). The second most highly differentially
expressed annotated gene (locus tag CNAG_01683 [accession no. CP022331.1]) be-
tween patient isolates showed highest homology to a sugar transporter-like gene
(STL1) from Saccharomyces cerevisiae implicated previously in glycerol metabolism. STL1
expression levels showed a signiﬁcant correlation with poor early fungicidal activity
(EFA), a clinical prognostic marker of patient outcome (25), and in situ hybridization
demonstrated STL1 expression in a brain of an HIV-infected patient with CM. Further-
more, mouse modeling was used to demonstrate attenuated virulence of an stl1Δ
strain, conﬁrming its role in mammalian virulence. STL1 was also found to be a target
gene of TOR, regulated by a novel regulatory pathway involving mRNA decay and a
multicomponent Cac2-Ecm15 nuclear shuttle regulatory complex. These studies thus
provide a direct link between STL1, TOR signaling, starvation response, and CAF1-
mediated regulation of microbial pathogenesis relevant to human fungal infections.
RESULTS
Transcriptional proﬁling of C. neoformans suggests similarity in adaptive stress
responses between human CSF and starvation medium at 37°C. Previous studies
utilized nutrient-deﬁcient media to simulate the environment of the host CSF and
successfully correlated expression levels of a CTR4 copper transporter with dissemina-
tion to the brain in a cohort of solid organ transplant patients (24). These conditions
were utilized to compare transcriptional proﬁles of a pathogenic C. neoformans strain
(H99, serotype A, molecular types VNI and VNII) (26) between nutrient-rich and nutrient-
poor environments and to compare the starvation adaptation proﬁles to that obtained
after transfer to pooled human cerebrospinal ﬂuid from patients with cryptococcal
meningitis (see Tables S1 and S2 in the supplemental material). Serotype A strains are
the predominant strains that cause HIV-associated CM and were selected to reduce
potential genetic confounding. A strong correlation was demonstrated between
expression-level changes between YPD and either CSF versus starvation medium at
37°C (Fig. 1A) (R2  0.79; slope non-zero P value of 0.0001). Transcriptional proﬁles
after transfer to each respective condition demonstrated not only common identities of
upregulated genes, but also the comparatively similar magnitudes of transcriptional
changes. Of 1,363 genes upregulated in starvation and 1,089 in CSF, 855 were upregu-
lated under both conditions, of which 332 were annotated sufﬁciently to allow Gene
Ontology (GO) term assignments (Fig. 1B). Compared to the overall annotated tran-
scriptome (Fig. 1C, left panel), transition of C. neoformans to either starvation conditions
or CSF resulted in an expansion of gene expression associated with the GO biological
term “carbohydrate metabolic processes,” including key enzymes involved in -oxidation,
the glyoxylate cycle, and gluconeogenesis (see Fig. S1 in the supplemental material). In
contrast, genes in the category “translation” were underrepresented in both media,
consistent with the slow growth anticipated under these conditions. Using GO func-
tional terms, transition of fungal cells to either starvation or CSF resulted in differential
expression of genes involved in the transport function (see Fig. S2 in the supplemental
material). These data thus emphasize similarities in gene expression proﬁles of C.
neoformans between nutrient deprivation and CSF, as well as a predominance of genes
involved in carbohydrate homeostasis and transport function.
Expression proﬁling of isolates from a cohort of AIDS-related CM identiﬁes a
putative sugar transporter-like gene, STL1, associated with clinical outcome
marker EFA. Further studies were then conducted to determine whether starvation-
induced genes may provide associations with clinical outcome that may help to
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understand human-related pathogenicity of the fungus. Transcriptional proﬁling under
starvation conditions was conducted as described below, which previously identiﬁed
the copper transporter gene CTR4 as a potential biomarker of brain dissemination in
solid organ transplant recipients (27) using a set of serotype A C. neoformans isolates
(molecular types VNI and VNII) from a cohort of HIV/AIDS patients described previously
(28). A demographic table of the cohort from which isolates were obtained is shown in
Table 1. Median age was 36 years, and all patients were treated with amphotericin
FIG 1 Expression proﬁling demonstrates a concordance of cryptococcal genes upregulated in fungus-
infected human cerebrospinal ﬂuid and starvation. (A) C. neoformans strain H99 was grown to the mid-log
phase in YPD and then subjected to starvation (Starv) in asparagine salts without glucose or sterile cerebro-
spinal ﬂuid (CSF) at 37°C for 3 h. RNA was recovered and subjected to microarray analysis, and values were
expressed as log2 ratios of expression in CSF/YPD. n 2 for each condition. (B) Venn diagram of genes
upregulated2-fold and adj P 0.05 after incubation in fungus-infected CSF or under starvation conditions.
(C) GO biological process term occurrence among genes upregulated under the indicated conditions. (D)
Transcriptional ratio of STL1/ACT1 determined by qRT-PCR of patient isolates compared to EFA (n 46;
regression analysis, n 2 degrees of freedom [df], P 0.05). (E) Expression ratios of STL1/ACT1 in survivors at
10weeks (S [n 35]) versus those who died (D [n 11]). (F) Sections of a brain autopsy specimen were
obtained from a 42-year-old man with HIV/AIDS who died of severe and diffuse C. neoformans infection and
were visualized by bright-ﬁeldmicroscopy (BF) or differential interference contrast microscopy (DIC) or stained
with Gomori methenamine silver stain (GMS), hematoxylin and eosin (H&E stain), calcoﬂuor white (CFW), or
C3-ﬂuorescein-labeled oligonucleotide probes for STL1 transcripts (STL1) by ﬂuorescent in situ hybridization in
the presence () or absence () of RNase A treatment. Arrows point to stained yeast cells. Bar  10m. (G
and H) Expression levels of STL1/18S rRNA under mid-log growth in YPD or 3 h of incubation under starvation
conditions or in the presence of 5M rapamycin (Rap). n 3 independent experiments. *, P 0.05, and **,
P 0.01, by Student’s t test. Error bars represent standard deviation.
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B-containing regimens. Despite therapy, 5 died by 2 weeks, and an additional 6 died by
10 weeks, generating a 10-week mortality of 11/45 (24%), typical of CM in developing
countries (3). Pretreatment covariables were signiﬁcantly different for mental status, as
measured by Glasgow coma score (P 0.02), but parameters including CSF initial
fungal burden, EFA, VN genotype, CSF opening pressure, or white blood cell (WBC) or
CD4 cell count did not differ signiﬁcantly. Expression proﬁles were compared using
analysis of variance (ANOVA) with adjustment, grouping patient isolates associated
with mortality at 10 weeks versus survivors. Ninety-one genes (28 annotated) showed
signiﬁcantly different expression in patients who died versus those who lived at least
10 weeks after therapy (see Table S3 in the supplemental material) (adjusted P value
[adj P] of0.02). The ﬁrst highly expressed gene was the nitroreductase family protein
gene (CNAG_02692 [CP022323.1]). The second most highly differentially expressed
gene showed highest homology to a sugar transporter-like gene, STL1, from S. cerevi-
siae previously implicated in glycerol transport (29, 30). STL1 was selected for further
study because of its putative role in alternative carbon metabolism and transport
function exemplifying the aggregate transcriptional changes in human CSF. STL1
expression levels by quantitative reverse transcription-PCR (qRT-PCR) of the clinical
isolates showed a signiﬁcant correlation with poor early fungicidal activity (EFA
[P 0.018]) (Fig. 1D (25), as well as a trend with clinical outcome (Fig. 1E) (P 0.07);
however, the latter was not statistically signiﬁcant, possibly due to nonmicrobiological
confounders, such as immune responses or delays in medical care. EFA is the rate of
fungal clearance in each of the HIV patient’s CSF during therapy and is a microbiolog-
ical prognostic marker of clinical outcome (25, 31). We did not ﬁnd a relationship
between STL1 expression and molecular genoype (P 0.73).In addition, STL1 expres-
sion was demonstrated in a brain autopsy specimen from an HIV/AIDS patient with CM
using ﬂuorescent in situ hybridization (FISH) (66/66 yeast cells with positive STL1 signal
versus 9/78 in RNase-treated negative-control slides; Fisher’s exact test, P 0.0001)
(Fig. 1F) (19). Furthermore, qRT-PCR demonstrated that STL1 expression was induced
during starvation, as well as in the presence of the TOR inhibitor rapamycin (Fig. 1G and
H). TOR is a particularly important pathway as the TOR inhibitors sirolimus and
everolimus are in widespread clinical use as immunosuppressants and may play a risk
factor in cryptococcosis (32). In summary, these data identify a starvation-induced
putative sugar transporter gene, STL1, associated with poor microbiological clearance
(EFA) during HIV-associated human infections.
STL1 plays a role in cryptococcal growth on alternative carbon sources and is
required for full virulence in mice. Further characterization demonstrated a role for
STL1 in expression of the virulence factors capsule (Fig. 2A) and laccase (Fig. 2B), but
STL1 was dispensable for mating (see Fig. S3A in the supplemental material). The
induction of capsule under the nutrient-deﬁcient (Glu) conditions was decreased
from a small rim of capsule in the wild type (WT) but markedly increased by overex-
pression under both YPD (yeast extract-peptone-dextrose) and nutrient-deﬁcient con-
ditions. Because of its putative role in alternative carbon homeostasis and poor fungal
TABLE 1 Baseline clinical and laboratory characteristics
Parametera
Result for patients
All Survived Died
n 45 34 11
Age, yrb 36 (21–62) 37 (21–62) 33 (23–51)
Male, % 53 53 55
Abnormal mental status, % 9 3 27
Fungal burden, log10 CFU/ml 5.9 5.9 5.8
EFA 0.51 0.55 0.37
CSF opening pressure, cm H2Ob 26 (7–76) 26 (10–76) 15 (7–42)
Genotype, % VNI 68 58 42
aCFU, colony-forming unit; CSF, cerebrospinal ﬂuid; EFA, early fungicidal activity.
bThe median is shown with range in parentheses.
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clearance and a trend toward worse survival in clinical strains showing increased
expression, we tested to see if STL1 overexpression could facilitate growth on alterna-
tive carbon sources and play a role in mammalian virulence using a mouse model.
Interestingly, STL1 overexpression (Fig. S3B) facilitated increased growth in nutrient
limitation medium containing 0.03% of either pyruvate, lactate or acetate—intermedi-
ates in gluconeogenesis and previously identiﬁed substrates within mammalian brains
during CM infections—as well as glycerol, which has been previously described for an
STL1 homolog from Candida (Fig. 2C) (29, 33). In addition, STL1 overexpression facili-
tated increased growth in nutrient limitation medium containing either 0.03% ribose or
citrate but not equivalent concentrations of glucose versus an identical strain trans-
formed with empty vector alone in identical copy number (Fig. 2D). These data extend
the spectrum of alternative carbon substrates related to fungal STL1. However, STL1 did
not facilitate growth on other sugars, including galactose, glucosamine, and rhamnose,
FIG 2 STL1 is required for growth on alternative carbon substrates, capsule formation, laccase activity,
and mammalian virulence. (A) Indicated strains were incubated on YPD or ASN without glucose (Glu)
agar for 3 days at 30°C and examined by India ink microscopy. Bar  5 m. (B) The indicated cells were
inoculated on ASN containing 100 mg/ml norepinephrine to assay production of melanin pigment by
laccase. (C) The indicated strains were diluted to an A600 of 1.0, and 1:5 serial dilutions (5 l) were plated
on YPD or ASN containing the indicated substrates (0.03%) and incubated at 30°C for 5 days. (D) In the
upper panels, the indicated strains were diluted to an A600 of 1.0, and 1:5 serial dilutions (5 l) were
plated on ASN containing the indicated substrates (0.03%) and incubated at 30°C for 7 days. In the lower
panels, the indicated strains were cultured with ASN broth containing the indicated substrates (0.03%),
and optical density at 600 nm (OD600) was calculated at the indicated time points. (E) Mice were
inoculated by tail vein (106 of the indicated cells), and progress was followed until the mice were
moribund. n 10 mice per group. P 0.0001 (left panel) and P 0.5 (right panel) by log rank test.
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suggesting carbon substrate speciﬁcity (Fig. S3C). In addition, the stl1Δ strain exhibited
moderately reduced virulence in an intravenous mouse brain dissemination model
compared to the wild-type strain (Fig. 2E, left panel). However, inoculation of C.
neoformans strains overexpressing STL1 resulted in no additional increase in virulence
in the highly virulent strain H99, compared with identical strains transformed with
empty vector alone (Fig. 2E, right panel). Lack of increased virulence could be because
the H99 strain used is already highly virulent (34). Taken together, these data suggest
that STL1 is associated with alternative carbon acquisition and plays a role in capsule,
laccase activity, and virulence.
The nuclear regulator CAC2 is a suppressor of STL1 and plays a role in capsule
and virulence in mice. We next sought to investigate mechanisms of starvation-
associated STL1 regulation. Previous work had identiﬁed ECM15 mRNA as a regulatory
target of the starvation/TOR-associated global virulence-associated deadbox (Vad1)
protein (35). Although ECM15 is not known to directly regulate gene expression, a
whole-proteome interaction study previously suggested that Ecm15 from the yeast
Saccharomyces cerevisiae interacts with a second S. cerevisiae protein, ScCac2 (36). Cac2
is a key constituent of the CAF-1 chromatin assembly factor, which assembles histones
H3 and H4 and mediates chromatin suppression of genes at subtelomeric locations and
tolerance to UV irradiation in both S. cerevisiae and C. neoformans (37, 38). However, its
precise role as a potential regulator remains unexplored in eukaryotes. Thus, we sought
to determine if a putative VAD1-ECM15-CAC2 regulatory pathway could play a role in
the starvation/TOR-dependent regulation of STL1 demonstrated in Fig. 1G and H.
We ﬁrst identiﬁed a cryptococcal CAC2 putative protein sequence demonstrating 33%
identity to that of the S. cerevisiae. The identity of C. neoformans CAC2 (CnCAC2) was
conﬁrmed by restoring UV tolerance to an Sccac2Δ mutant strain (Fig. 3A). To directly
evaluate CAC2 in C. neoformans, the cryptococcal cac2Δ strain was generated and demon-
strated increased expression of STL1 by qRT-PCR (Fig. 3B). Early studies suggested that
orthologs of CAF-1 members such as Cac2 are associated with suppression of genes in the
subtelomeric region (37), which include cryptococcal genes such as FRE7 (ferric-chelate
reductase: CNAG_00876 [CP022325.1]), CNAG_05333 (XM_012198174.1), and the HpcH/
Hpa1 family protein gene (CNAG_06874 [XM_012194223.1]) (see Table S4 in the
supplemental material); however, the STL1 gene does not reside within this region
(location in chromosome 11 [CP003830.1], positions 603867 to 606604). Thus, to
identify a possible direct STL1 Cac2-speciﬁc DNA binding region(s), chromatin immu-
noprecipitation (ChIP) was performed using an anti-green ﬂuorescent protein (anti-GFP)
antibody directed against a Cac2-GFP fusion protein. These studies demonstrated Cac2
binding within a 100-bp fragment centered at 700 bp from the transcriptional start
site of STL1, as well as that of FRE7 under the nutrient condition (Fig. 3C, top panel). In
addition, STL1 Cac2-speciﬁc DNA binding efﬁciency was reduced under both starvation
(Fig. 3C, middle panel) and rapamycin (Fig. 3C, bottom panel) conditions. To determine
the functional signiﬁcance of the binding, we tested expression levels of an Stl1-GFP
fusion having serial deletions of the STL1 promoter (positions 1,000, 500, and 50
from the transcript start site) on basal transcriptional activity in C. neoformans (see
Fig. S4A in the supplemental material). The plasmid containing an STL1 open reading
frame (ORF) with various lengths of the STL1 5=-promoter–GFP fusion gene were
transformed into wild-type or cac2Δ C. neoformans strains. Empty vector was used as a
control. These results indicated the presence of basal transcription originating from the
region from 1000 to 500 of STL1 under both nutrient-replete (YPD) and nutrient-
poor (Glu) conditions, corresponding to the region of Cac2 binding by ChIP. However,
under the nutrient-rich condition, a subpopulation of WT cells displayed suppression using
episomal constructs which replicate autonomously, which could suggest a requirement for
chromatin-dependent promoter-binding factor(s) for more effective CAC2-dependent chro-
matin silencing (39). Thus, linear PCR fragments containing the indicated promoter, STL1
coding region, and selection marker were transformed into WT and cac2Δ strains as
integrated fragments, demonstrated comigration with genomic DNA on Southern blot
analysis. As shown in Fig. 3D and E, the integrated construct exhibited more effective
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repressed STL1 expression under nutrient-rich conditions (YPD), which was derepressed
under either nutrient-poor conditions (Glu) or in the cac2Δ mutant strain. Interestingly
there was heterogeneity in Stl1-GFP expression in the cac2Δ strain, which may suggest
posttranslational modiﬁcation of the fusion protein.
FIG 3 Cac2 is a repressor of STL1 and capsule and overexpression reduces virulence in mice. (A) The indicated strains were
diluted to an A600 of 1.0, and 1:5 serial dilutions (5l) were plated on YPD or on YPD with UV irradiation (UV) for 1min and
incubated at 30°C for 3 days. (B) qRT-PCR of STL1 of indicated strains grown to the mid-log phase in YPD and ASN
without glucose (Glu) media. n 3 independent experiments. *, P 0.05, and **, P 0.01, by Student’s t test. (C)
Chromatin immunoprecipitation (ChIP) of a Cac2-promoter complex. Nuclear extract from induced cryptococcal cells
expressing a Cac2-GFP fusion protein was immunoprecipitated using an anti-GFP antibody (-GFP Ab) or control IgG
(IgG only) and assayed by PCR for the presence of the indicated regions of STL1, FRE7 promoter, or control promoter
sequences of ACT1. (D and E) Effects of serial deletion of the STL1 5=-promoter (1000 from the transcript start site) on
basal transcriptional activity in C. neoformans. Linear constructs containing STL1 ORF with indicated regions of the STL1
5=-promoter–GFP fusion gene were transformed into WT or cac2Δ strains of C. neoformans, integration was conﬁrmed
by Southern blotting, and cells were grown to the mid-log phase in YPD or ASN salts without glucose (Glu), and the
population was subjected ﬂow cytometry or microscopy (DIC or GFP ﬂuorescence microscopy). Cells transformed with
empty vectorwere used as control. Bar5m. (F) The indicated strainswere inoculated onto the indicatedmedia, recovered,
and visualized by India ink microscopy. (G) Indicated cells were inoculated on ASN containing 100mg/ml norepinephrine to
assay production of melanin pigment by laccase. (H) Mice were inoculated by tail vein (106 cells of the indicated strains), and
progress was followed until mice were moribund. n10 mice per group. P0.7 (left panel) and P0.0001 (right panel) by
log rank test.
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Further characterization of CAC2 demonstrated that, similar to the STL1 overexpres-
sion strain, the CAC2 deletion strain showed increased capsule expression under
nutrient-poor conditions (Fig. 3F), but there was little effect on melanin formation
(Fig. 3G), mating (Fig. S3A), or virulence (Fig. 3H, left panel). However, overexpression
of CAC2 resulted in markedly reduced virulence in mice (Fig. 3H, right panel), compared
to an empty vector control strain, suggestive of a suppression of genes involved in
virulence, such as STL1. The cac2Δ strain was thus a phenocopy of the STL1 overex-
pressor strain, though epistatic experiments demonstrated that STL1 overexpression in
the CAC2 overexpressor strain could not restore capsule induction, suggesting that
CAC2 may suppress additional genes involved in capsule synthesis besides STL1
(Fig. S4B). However, the data do suggest that CAC2 is a transcriptional repressor of STL1
and is associated with capsule expression and murine virulence.
Nuclear localization of CAC2 is nutrient dependent and requires ECM15. Sac-
charomyces interactome studies (36) suggested that ECM15 may regulate CAC2 by a
posttranslational interactive mechanism. ECM15 in S. cerevisiae is a nonessential poorly
understood protein, proposed to be involved in cell wall competency (36, 40). Inter-
estingly, deletion of ECM15 resulted in at least a 2-fold increased transcription (Fig. 4A)
FIG 4 Cac2 and Ecm15 shares overlapping expression proﬁles and undergoes nutrient- and TOR-
dependent nuclear localization. (A) Venn diagram of genes showing2 increased transcription relative
to WT and adj P 0.05 after deletion of ECM15 or CAC2. (B) C. neoformans cells expressing Cac2-GFP or
Ecm15-mCherry were incubated in YPD, ASN without glucose (Glu), or YPD containing rapamycin and
observed by ﬂuorescence (DAPI, Cac2, or Ecm15) or differential interference contrast (DIC) microscopy.
Bar  5 m. (C) Indicated strains were incubated on YPD or ASN without glucose (Glu), recovered, and
observed by India ink microsocopy. (D) Cells expressing Cac2-GFP in wild-type (WT) or ecm15Δ strains
were incubated in YPD ASN without glucose (Glu) or YPD containing rapamycin and observed by
ﬂuorescence or by DIC microscopy. Bar  5 m.
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(adj P 0.05) of 106 genes, while transcription of only 8 genes increased after CAC2
deletion, 4 of which were shared with ECM15. Interestingly, the gene showing highest
suppression by both ECM15 and CAC2 was STL1 (Table S4). In addition, examination of
protein sequences using cNLS Mapper (41) identiﬁed putative nuclear localization
sequences in Ecm15 in the region D63 to A91 and Cac2 in the region E778 to V802 (see
Fig. S5 in the supplemental material). Thus, to assess for possible regulatory interac-
tions, as well as common nuclear localizations, in Cryptococcus and whether this could
change in response to nutrient starvation or rapamycin, both proteins were tagged
with GFP. These studies demonstrated colocalization of Cac2-GFP (Pearson correlation
coefﬁcient [PCC]  0.77) and Ecm15-mCherry (PCC  0.87) with the nuclear dye
4=,6-diamidino-2-phenylindole (DAPI) (Fig. 4B) and with each other (PCC  0.77) under
nutrient-rich conditions (YPD) with cytoplasm localization under starvation or in the
present of rapamycin, consistent with a possible role as nuclear suppressors under
nutrient-rich conditions and derepression under starvation conditions. Interestingly, rapa-
mycin resulted in cytoplasmic localization of EMC15-mCherry with an additional suppres-
sion of visible ﬂuorescence in starvation, which could be due to transcriptional suppression
by VAD1, as alluded to above. Epistatic studies were next conducted, which demonstrated
that the increased production of capsule in the ecm15Δ mutation could be readily sup-
pressed by CAC2 overexpression, but ECM15 overexpression was not as effective at sup-
pressing the increased capsule phenotype of the cac2Δ mutant (Fig. 4C), suggesting that
ECM15 is hypostatic to CAC2. Additional studies demonstrated that deletion of ECM15
resulted in mislocalization of the Cac2-GFP fusion protein under nutrient-replete conditions
(WT, CAC2-GFP-DAPI; PCC 0.77) to the cytoplasm (ecm15Δ, CAC2-GFP-DAPI; PCC 0.57),
similar to that during starvation (WT, CAC2-GFP-DAPI; PCC 0.53) or in rapamycin-treated
cells (WT, CAC2-GFP-DAPI; PCC  0.24) (Fig. 4D). These results suggest that Ecm15 is
required for Cac2 nuclear targeting, leading to downstream repression of virulence-
associated phenotypes and genes, including STL1.
ECM15 plays a role in capsule, mating, and cell wall stability and is regulated
by VAD1. Further studies were then conducted to further characterize the cryptococcal
ECM15 gene and characterize its relationship with starvation regulatory pathways that
could play a role in regulation of genes such as STL1. The deduced amino acid sequence
of the cryptococcal Ecm15 showed 66.8% identity to its respective homolog in S.
cerevisiae. Susceptibility of an Scecm15Δ mutant to the cell wall active agent calcoﬂuor
white as previously reported (42) was complemented by the cryptococcal ECM15 gene
(Fig. 5A). These results suggest that CnEcm15 is a functional homolog of ScEcm15p.
Phenotypic studies shown in the preceding ﬁgure (Fig. 4B) demonstrated a role for
ECM15 in extracellular capsule as well as mating, with a subtle effect on melanin
formation (Fig. 5B). These studies thus implicate a role for ECM15 in the regulation of
several virulence-associated phenotypes as well as mating of C. neoformans.
Extending these results to cell wall phenotypes associated with virulence, as sug-
gested by studies in S. cerevisiae, the cryptococcal ecm15Δ mutants were found to
exhibit increased susceptibility to the ionic detergent SDS (Fig. 5C). Interestingly the
ecm15Δ mutant also displayed poor growth on nutrient-poor agar consisting of aspar-
agine salts (ASN) without glucose (Fig. 5C), similar to that of the stl1Δ mutant. In
addition, the Cnecm15Δ strain exhibited attenuated virulence in a mouse model
(Fig. 5D, left panel). Interestingly attenuated virulence was also exhibited by an
ECM15-overexpressing strain (Fig. 5D, right panel). ECM15 was overexpressed using an
ACT1 constitutive promoter and compared with strains expressing empty vector alone
in equivalent copy number, as previously described (43). As alluded to above, the
cryptococcal RNA chaperone Vad1 regulates gene expression in a starvation-
dependent fashion by recruiting mRNA to a decapping complex protein, Dcp2, leading
to transcript degradation (19), and previous studies demonstrated that VAD1 binds
ECM15 mRNA (35). In the present study, ECM15 mRNA binding to Vad1 was conﬁrmed
by qRT-PCR after radioimmunoprecipitation of a c-myc-Vad1 fusion protein (RIP-qRT-
PCR) compared to that of an equivalent precipitation using an untagged strain (Fig. 5E).
In addition, a vad1Δ mutant showed accumulation of ECM15 transcripts compared with
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the wild type from cells incubated under starvation conditions (Fig. 5F), suggesting that
VAD1 is a repressor of ECM15. Taken together, these data suggest that deletion of
cryptococcal VAD1 increases transcript abundance of ECM15, a regulator of capsule,
mating, laccase, cell wall stability, starvation tolerance, and mammalian virulence.
In summary, these data identify a starvation-dependent epistatic regulatory path-
way involving VAD1, ECM15, and CAC2 controlling growth on alternative carbon
sources, expression of the virulence factors capsule and laccase, and mammalian
virulence (Fig. 6).
DISCUSSION
Pathogen survival and virulence entail selection for traits necessary within the
infective niche. For opportunist pathogens such as C. neoformans, evolutionary pres-
sures exerted during residence in nutrient-poor soil or free-living amoebae (9), or in the
presence of diphenolic toxins within plants (8), have likely shaped expression patterns
necessary for effective mammalian infection. After infection, C. neoformans is also
FIG 5 VAD1 is a repressor of ECM15, a regulator of capsule, laccase activity, and virulence. (A) The
indicated strains were diluted to an A600 of 1.0, and 1:5 serial dilutions (5 l) were plated on YPD medium
or YPD containing 50 g/ml of calcoﬂuor white (CFW) and incubated at 30°C for 3 days. (B) The indicated
strains were inoculated on ASN containing 100 mg/ml norepinephrine and observed after 2 days at 37°C
(upper panel). Indicated MAT strains were coincubated with a MATa mating partner (strain KN99) on
nitrogen-limiting mating medium (V8 agar) for 3 weeks at room temperature. The edges of the mating
mixtures were photographed (40). Bar 500 m (lower panel). (C) The indicated strains were diluted
to an A600 of 1.0, and 1:5 serial dilutions (5 l) were plated on YPD, ASN, or YPD containing SDS and
incubated at 30°C for 3 to 7 days. (D) Mice were inoculated by tail vein (106 [left] or 103 [right] of the
indicated strains), and progress was followed until they were moribund. n 10 mice per group. P
0.0001 (left panel) and P 0.01 (right panel) by log rank test. (E) Lysates from cells expressing a
c-myc-tagged Vad1 fusion protein incubated under the indicated conditions were immunoprecipitated
followed by RT-PCR/gel electrophoresis using primers for the indicated gene transcripts. (F) Steady-state
transcript levels of ECM15 from indicated strains grown to the mid-log phase in YPD or ASN salts without
glucose (Glu). n 3 independent experiments. *; P 0.05 by Student’s t test.
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thought to reside in the human host for a prolonged time as a latent, growth-arrested
organism (7). Thus, nutrient limitation could provide a common condition that shapes
adaptation and pathogen optimization within diverse environments and was the
subject of the present study.
In this study, expression patterns of C. neoformans within human cerebrospinal ﬂuid
from actively infected patients was highly correlated with that induced under starvation
conditions at 37°C in both identity and levels of transcription. In addition, of the 222 genes
previously reported to be upregulated after incubation in the macrophage cell line J774.1
(12), 147 were also found to be upregulated in CSF in the present studies, and of the 323
genes upregulated in free-living amoeba reported in the same paper, 164 were also
upregulated in CSF and similar numbers in starvation, suggesting metabolic response
commonality between these infective niches. Brain infections with C. neoformans are
typically associated with low CSF glucose levels (3), and the pooled patient CSF used in the
present studies reﬂected this. Interestingly, several studies suggest that the macrophage
phagolysosome is also a nutrient-deprived environment (4, 43), implicating starvation
response pathways in cryptococcal virulence in a number of human infective niches.
Speciﬁcally, CSF incubation resulted in reduced expression of genes related to protein
translation typical of growth limitations from reduced nutrients (44). In contrast, exposure
to infected human CSF resulted in increased gene expression of processes related to sugar
transport and alternative substrate utilization exempliﬁed by genes involved in -oxidation,
the glyoxylate cycle, and gluconeogenesis. This metabolic reprogramming toward more
efﬁcient utilization of alternative substrates is shared by other organisms, such as Candida
albicans (45). However, these expression patterns differed from that reported from RNA
isolated directly from patient CSF of two CM patients, which more closely resembled that
from nutrient-replete media and could have reﬂected an unusually vigorous growth
condition or the higher levels of CSF glucose concentrations typical of some HIV/AIDS
patients (46). However, such disparate results caution that expression of diverse strains from
individuals with varied clinical presentations may be required to understand heterogeneity
within the human infective niche.
Thus, the present studies utilized multiple patient isolates from a cohort of previ-
ously described HIV/AIDS patients presenting with cryptococcal meningoencephalitis
and treated uniformly with amphotericin-based regimens to study gene expression
under the same nutrient limitation conditions described above. These studies identiﬁed
an STL1 sugar transporter whose expression levels were negatively associated with low
FIG 6 Scheme of starvation regulation of STL1 related to capsule formation and mammalian
virulence.
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rates of clearance from the CSF and showed a trend toward increased 10-week
mortality. STL1 is named as a sugar transporter gene but has also been implicated in
glycerol acquisition (29, 47), as was found for C. neoformans in the present studies with
additional roles in lactate, pyruvate, and acetate metabolism. Interestingly, glycerol is
elevated during cell membrane degradation and brain injury (48), and acetate has been
demonstrated in large amounts by magnetic imaging spectroscopy during human
cryptococcal infections (49, 50), and thus, STL1 may play a role in acquisition of these
metabolites during infection. Early fungicidal activity (EFA) is a research measurement
of CSF microbiological clearance in patients and is an important clinical prognostic
marker of mortality. It reﬂects both microbiological virulence and drug responses, as
well as host aspects of the infection (51). Notable in the present studies was reduced
expression of the virulence factor laccase in the stl1Δ mutant. High laccase expression
has previously been shown to be correlated with low EFA and worse patient survival,
and higher expression could have contributed to microbiological retention in the CSF
(23). While elevated STL1 expression tended to suggest poor survival, large variability in
expression levels between wild-type C. neoformans strains could have impacted the
signiﬁcance of the relationship. Such variability was previously demonstrated by other
cryptococcal biomarkers, such as CTR4, which demonstrated over 100-fold difference
among clinical isolates from a cohort of solid organ transport patients (24). There also
exist a number of potential nonmicrobiological factors that affect mortality. For exam-
ple, initial patient mental status was more frequently altered in those who died and is
an important risk factor for death (3), as was found in our cohort. Other previously
reported clinical risk factors such as age and opening pressure on lumbar puncture did
not differ between groups in our study. The relative immune response of the host could
also be an important contributor to death in primary infections with C. neoformans.
However, previous studies have shown only minor associations between mortality and
markers such as CD4 count, peripheral white blood cell count, or CSF white cell count
(3). The present cohort did not include patients with cryptococcal immune reconstitu-
tion syndrome (cIRIS), where immune responses may be more predominant (52), or
other inﬂammatory syndromes associated with non-HIV-infected individuals (53). In
addition, increased expression alone does not necessarily identify genes important to
virulence, exempliﬁed by the virulence factor laccase, which is downregulated at
elevated temperatures (54), or the highly upregulated PTP1 sugar transporter, which
also demonstrated no such role in virulence (12). Other upregulated genes such as PCK1
have had variable roles in virulence, with mutants attenuated in mice (13) but not in
rabbits (14). All of these considerations led us to attempt to provide additional
validation of the human cohort fungal expression studies by utilizing a model with
genetically deﬁned C. neoformans isolates. These studies did show differences in
virulence between wild-type and stl1Δ strains, further implicating STL1 in fungal
virulence. The intravenous model was tailored to the clinical cohort that all had brain
infections and focuses on pathogen-related outcomes of murine brain infection, rather
than a pulmonary (intratracheal or posterior pharyngeal inoculation) model, in which
survival is more related to altered lung pathology (55). However, additional cohorts
reﬂecting different clinical scenarios may be required to fully understand the complex-
ity of the cryptococcus-human host interaction.
The present studies also identiﬁed an important molecular pathway in starvation
response and its relation to human infections by examining STL1 as a target gene of the
starvation/TOR stress pathway. TOR is an important mediator of the starvation/stress
response, as well as cryptococcal survival (56), and inhibitors of TOR such as sirolimus
and everolimus are in widespread use in patient populations at risk for CM, including
transplant recipients (57). More recent work has shown that many TOR-dependent
starvation processes are regulated via mRNA stability in yeast (58), and an important
TOR-dependent regulator of mRNA stability, VAD1, is also a major virulence determi-
nant in C. neoformans (19). The present studies identiﬁed a role for TOR/VAD1-
dependent regulation of a novel CAC2/ECM15 regulatory pair of nuclear factors that
demonstrated starvation-dependent regulation of STL1. In C. neoformans, a deletion
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mutant of CAC2 was previously found to exhibit normal growth characteristics and a
slight susceptibility to UV irradiation (59). In S. cerevisiae, deletion of CAF-1 subunits
such as CAC2 results in increased UV sensitivity and defects in subtelomeric gene
silencing (37), suggesting a role in stress response, but the present studies are the ﬁrst
describing the role of Cac2 as a dynamic regulator of nutrient levels. As expected of an
STL1 repressor, CAC2 overexpression resulted in reduced virulence in mice. The viru-
lence phenotype was more evident in the CAC2 overexpressor than the STL1 knockout
mutant and suggests a combined effect on virulence of multiple CAC2-regulated genes,
some of which may not have reached signiﬁcance in the patient cohort. Another
ECM15/CAC2-dependent gene, CNAG_00876 (CP022325.1), has been previously identi-
ﬁed as a ferric-chelate reductase gene (FRE7), regulating the important iron acquisition
pathway in C. neoformans (60). The FRE7 gene was also upregulated in the patient
cohort, although this did not approach signiﬁcance and was not further characterized.
The STL1 regulatory pathway (Fig. 6) has been simpliﬁed into a linear chain for study
purposes but is likely much more complex due to the presence of other known
virulence pathways related to alternative carbon acquisition/glycerol acquisition and
metabolism, including HOG1, calcineurin, PI3K, PLC1, and PKA1 (19, 61–66). Repression
by CAC2 may be chromatin dependent as promoter studies demonstrated greater
CAC2-dependent suppression in glucose when the STL1 promoter constructs were
integrated. Indeed, previous studies suggested that the Cac2-Caf1 complex binds
preferentially to modiﬁed histones that have not been reported in plasmid DNA (67)
and may thus be required as part of the chromatin repressor complex (68). The related
factor Cac1 has recently been shown by single-particle electron microscopy to act as a
histone binding platform, linking Cac2 within the Caf1-histone assembly complex
implicated in maintenance of molecular architecture (69); however, the present studies
extend the role of Cac2 within the Caf1 complex from merely a housekeeping function
to that of a dynamic regulator of TOR-mediated nutrient stress response. Future studies
may provide more detailed structural mechanistic insight for this complex regulation in
eukaryotes and highlight the utility of C. neoformans as a model eukaryote. Neverthe-
less, the present data demonstrate that the VAD1/ECM15/CAC2 regulatory pathway is
integral to the connection of the starvation/TOR virulence response through the sugar
transporter gene STL1 (Fig. 6).
MATERIALS AND METHODS
Ethics statement. Written informed consent was obtained, and the study was approved by the
Research Ethics Committee of the University of Cape Town, the Medicines Control Council of South
Africa, and the London-Surrey Borders Research Ethics Committee on behalf of St. George’s University of
London and by an institutional review board (IRB)-approved protocol from the National Institute of
Allergy and Infectious Diseases. All experimental procedures were conducted under a protocol approved
by the Institutional Animal Care and Use Committee of the Intramural Research Program of the NIAID,
NIH (protocol no. LCIM12E). All experimental studies were approved by the relevant NIAID Animal Care
and Use Committee, as per the Guide for the Care and Use of Laboratory Animals (70) from the National
Research Council of the National Academies, Washington, DC.
Study subjects. Subjects providing isolates for expression analysis were control participants in a
randomized trial of adjunctive gamma interferon (IFN-) in HIV-infected patients and a randomized trial
examining alternative amphotericin B combinations, both described previously (71). We attempted to
standardize the antifungal drug factor impact on EFA by only selecting for inclusion patients from a
single clinical trial site treated using similar study protocols with amphotericin B-based induction
regimens (i.e., no ﬂuconazole and no adjunctive IFN-, both of which we know lead to signiﬁcantly
slower/faster clearance). CSF from 2 pooled donors was provided from stored specimens under an
observational protocol previously described (53). As shown in Table 1, the 45 patients had their age, CD4
count, etc., recorded. All strains were previously serotyped to be serotype A and were genotyped by
multilocus sequence typing (MLST) (72).
Strains and media. Experiments were conducted in a genetic background of C. neoformans WT
strain serotype A H99 (MAT [ATCC 208821]), which was the kind gift of J. Perfect. A complete list of
strains used in this study is described in Table S5A in the supplemental material. Escherichia coli DH10B
(Invitrogen) was the host strain for recovery and ampliﬁcation of plasmids. The fungal strains were grown
in YPD (2% glucose, 1% yeast extract, 2% Bacto-peptone) or YPD agar (YPD and 2% agar). Asparagine
minimum selective medium (ASN) for transformant selection and incubation of YPD-grown mid-log cells
for transcriptional studies or for detection of laccase production were described previously (73). V8 juice
medium was used for mating assays as described previously (74).
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Microarray experiments. Isolates from patients in Table 1 or the H99 lab strain were grown to
mid-log phase and then transferred to asparagine medium without glucose (1 g/liter asparagine, 10 mM
sodium phosphate [pH 7.4], and 0.25 g/liter MgSO4) or human CSF pooled from 4 patients with
cryptococcal meningitis (having glucose concentrations from 10 to 25 mg/dl [0.55 to 1.4 mmol/liter]) and
incubated for 3 h at 37°C, and RNA was recovered as described previously (24). Serotype A H99-based
microarrays (hybridization probe sequences described previously in reference 27) with two unique
probes (3 replicate features per probe) for each of 6,969 transcripts (1 per locus) were used for expression
proﬁling. Two-color cohybridizations were performed with a common reference sample in the Cy5
channel on each array. Agilent Feature Extraction software (v.11.5.1.1, protocol GE2_107_Sep09) esti-
mated the median pixel intensity of each feature, which was then log2 transformed. Replicate RNA
samples from CSF or starvation buffer conditions were generated in two independent experiments. The
reference sample was grown in YPD and used both for loess normalization and as a comparison
condition in ANOVA. Each feature signal was normalized by loess (locally weighted scatterplot smooth-
ing) and averaged per locus (3 replicates of two probes for 1 transcript per locus). A mixed-effects ANOVA
model (ﬁxed effect of growth medium, random effect of array identiﬁcation) was computed, and expression
difference estimates for each gene were calculated for CSF or starvation medium versus YPD. For the patient
isolates (Table 1), the reference pool was created from 12 of the samples. Probe signals were summarized as
the median of the 3 replicate features, then loess-normalized ratios against the cognate reference signal were
averaged for the two probes per locus. A mixed-effects ANOVA model (ﬁxed effect of survival or mortality
time, random effect of study group, two levels) was computed, and expression difference estimates for each
gene were calculated for week 2 mortality versus survived, week 10 mortality versus survived, or both week
2 and week 10 mortality versus survived. For both experiments, the false-discovery rate (FDR) was estimated
from raw ANOVA P values to compensate for multiple testing of 6,969 genes. SAS and JMP/Genomics software
(SAS, Cary, NC) was used for statistical analysis.
Overexpression, disruption, and complementation of ECM15, CAC2, and STL1 in C. neoformans.
Standard methods were used for overexpression, disruption, and complementation of the ECM15, CAC2,
and STL1 genes in strain H99 (MAT), as described previously using two PCR-ampliﬁed fragments and a
1.3-kb PCR fragment of the URA5 gene previously described to effect a deletion within the target coding
regions and was complemented using a 1-kb of up- and downstream genomic fragment of the target
genes (13, 75, 76). Complementation in all cases retained the original deletion construct. The primers
used in this study are listed in Table S5B.
Ecm15-mCherry and Cac2-GFP fusion proteins. The cryptococcal shuttle vector pORA-YP142 (77)
was used to express a fusion between the Ecm15 protein and a synthetic mCherry protein (Cneo-
mCherry), utilizing C. neoformans codon usage produced by standard methods (75). The plasmid was
digested with NdeI and PstI, and a PCR-ampliﬁed fragment of the H99 ECM15 gene-containing promoter
region was digested with NdeI and PstI and ligated into compatible sites to produce YP148. The plasmids
were recovered, the sequences were veriﬁed, and the plasmids were linearized with SceI and transformed
into C. neoformans H99 MAT FOA cells by electroporation using standard methods (78). All cell
preparations grown on nonselective medium were assayed at the end of each experiment by simulta-
neous inoculation of selective and nonselective plates to verify 90% retention of plasmid. Colocaliza-
tion was observed using a Leica DMI 6000B microscope with a Hamamatsu camera using LAS AF6000
v.2.1.2 software (Leica). Pearson’s correlation coefﬁcients of colocalization were calculated on a minimum
of 20 cells using Leica LASX software. Predicted nuclear localization sequences were identiﬁed in the
Ecm15 and Cac2 proteins using cNLS Mapper (41).
qRT-PCR experiments. C. neoformans H99 strains were grown on YPD or ASN without glucose.
Real-time PCR was performed using primer sets as described in Table S5B. Reverse transcription was
performed on DNase-treated RNA using the iScript kit (Bio-Rad Laboratories) according to the manu-
facturer’s protocol. PCRs were set up using iQ SYBR green supermix (Bio-Rad Laboratories), according to
the manufacturer’s protocol. qRT-PCR was performed using a Bio-Rad iCycler (MyiQ2).
FISH. Sections of a brain autopsy specimen were obtained from a 42-year-old male who died of
severe and diffuse C. neoformans infection as reported previously (13). Fluorescent in situ hybridization
(FISH) was performed as previously described (19). Brieﬂy, cells were washed once with 1 phosphate-
buffered saline (PBS) and ﬁxed for 4 h with 4% wt/vol paraformaldehyde in PBS at 4°C. Probes were
labeled at the STL1 ORF with C3-ﬂuorescein (LGC Bioresearch [Table S5C]). For the negative control,
samples were treated with RNase A (50 g/ml) for 1 h at 37°C, prior to the hybridization step. Fixed cells
were hybridized in 20 l of hybridization buffer (0.9 M NaCl, 0.01% wt/vol SDS, 20 mM Tris-HCl [pH 7.2],
20% formamide) with 5 ng of C3 ﬂuorescein-labeled probe and incubated at 46°C for 16 h. After
incubation, cells were pelleted by centrifugation and resuspended in 1 ml of prewarmed washing buffer
(20 mM Tris-HCl [pH 8.0], 0.01% wt/vol SDS, 5 mM EDTA, 225 mM NaCl) for 30 min at 46°C. The slides were
then mounted in ProLong Gold antifade reagent (Invitrogen) and observed using a Leica DMI 6000B
microscope with a Hamamatsu camera and LAS AF6000 v.2.1.2 software (Leica). Cells were scored as
positive by a blind observer and analyzed by Fisher’s exact test.
Measurement of capsular size and virulence studies. To induce capsule, yeast cells were grown
on ASN at 30°C for 4 days. Capsule was measured by microscopy after the fungal cells were suspended
in India ink (79) and laccase by melanin production on norepinephrine agar. Virulence studies were
conducted according to a previously described intravenous mouse meningoencephalitis model (80)
using 10 CBA/J mice for each C. neoformans strain. All experimental procedures were conducted under
a protocol approved by the Institutional Animal Care and Use Committee of the Intramural Research
Program of the NIAID, NIH.
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ChIP assay. The ChIP assay was adapted and modiﬁed from a previously described protocol (81) for
C. neoformans. PCR detection of the STL1 gene was performed using a primer set described in Table S5B.
Input DNA was used as a positive control, consisting of unprecipitated genomic DNA as a loading control
and to show intact function of each primer set and PCR.
Promoter deletion studies. The 5=-truncated promoter sequences were obtained by PCR using a
single reverse primer and different forward primers (positions1000,500, and20 from the transcript
start site) carrying BglII and NdeI restriction sites (Table S5B). The ampliﬁed fragments were inserted
upstream of the GFP gene coding region of the plasmid, producing a series of STL1 promoter-STL1-GFP
vectors. After veriﬁcation by sequence analysis, the conﬁrmed constructs or linear ampliﬁed fragments
containing the indicated upstream region, STL1 reading frame, and GFP marker and terminator as
indicated were transformed into WT or cac2Δ strains of C. neoformans. Integrated constructs were
conﬁrmed by uncut Southern blots (81). These strains were subjected to microscopy (differential
interference contrast [DIC] or GFP ﬂuorescence) or ﬂow cytometry (ﬂuorescein isothiocyanate [FITC]) to
determine the promoter activity of STL1 under glucose or starvation conditions.
Statistics. Errors were expressed as standard error of the mean (SEM). Fluorescence-positive cells
(Fig. 1) were scored in a blind fashion and analyzed by Fisher’s exact test.
Calculations involving statistics available from the ANOVA output (JMP/Genomics version 8.0) include
mean square error (MSE), error degrees of freedom (DDF), model degrees of freedom (NDF), and the
proportion of the variance accounted for by the model (R2). From these we derive the following: SSE (sum
of squares error)  MSE  DDF, SSM (sum of squares model)  SSE  R2/(1  R2), MSM (mean square
model)  SSM/NDF, and F ratio  MSM/MSE.
Raw P values are retrieved from the cumulative probability distribution of the F ratio using the
parameters F ratio, NDF, and DDF (e.g., with the SAS function PROBF), where n (total samples)  NDF 
DDF  1 and C (number of groups)  NDF  1.
A hypothetical increase of n samples per group by iteration i (steps) leads to an increase in DDF,
DDF(ni)  n  2  n  i – C, which propagates to recalculations of SSE, SSM, F ratio, and P value for
i 1,2,3. . . iterations.
Data availability. Data from the microarray experiments have been deposited in the National Library
of Medicine Gene Expression Ontology (GEO) database.
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